LMAT | tickerfilter.com

Fundamental analysis

61%

Profitability 74%

Dept financing 10%

Liquidity 69%

Performance 58%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

-1.51%

1 Month

3.04%

3 Months

15.07%

6 Months

28.71%

1 Year

56.71%

2 Year

89.15%

Key data

Stock price

$90.30

P/E Ratio

53.84

DAY RANGE

$88.87 - $90.72

EPS

$1.67

52 WEEK RANGE

$43.47 - $92.90

52 WEEK CHANGE

$0.58

MARKET CAP

2.029 B

YIELD

0.68%

SHARES OUTSTANDING

22.469 M

DIVIDEND

$0.16

EX-DIVIDEND DATE

08/15/2024

NEXT EARNINGS DATE

10/30/2024

BETA

1.05

PUBLIC FLOAT

AVERAGE 10 VOLUME

$96,002

AVERAGE 30 VOLUME

$119,797

Company detail

CEO: George LeMaitre
Region: US
Website: http://www.lemaitre.com/
Employees: 411
IPO year: -

Issue type: Common Stock
Market: XNAS
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing

lemaitre vascular is a provider of devices and implants for the treatment of peripheral vascular disease, a condition that affects more than 20 million people worldwide. the company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. the company's diversified product portfolio consists of brand name devices used in arteries and veins outside of the heart. the company is listed on nasdaq.

LMAT - Lemaitre Vascular Inc